2022-08-21 高雄萬豪酒店 10F皇喜會議室 10D-1
時間主題
13:10 ~ 13:20
PD09-1: The real-world outcome with Abiraterone acetate plus prednisone in Asian men with metastatic castrate-resistant prostate cancer treated in China Medical University Hospital
講者: 蔡正晏 座長: 黃昭淵,
高建璋
13:20 ~ 13:30
PD09-2: Preoperative MRI and clinical factors are predictors for biochemical recurrence in high and very high risk prostate cancer
講者: 楊晨洸 座長: 黃昭淵,
高建璋
13:30 ~ 13:40
PD09-3: Could 18F-FluciclovinePET/CT be a game changer in prostate cancer with biochemical recurrence?
講者: 胡蔚祥 座長: 黃昭淵,
高建璋
13:40 ~ 13:50
PD09-4: Efficacy of immune check point inhibitors in metastatic urothelial carcinoma is associated with chemotherapy response, a real world retrospective study
講者: 陳韋辰 座長: 黃昭淵,
高建璋
13:50 ~ 14:00
PD09-5: Perineural invasion can predict prognosis for upper tract urothelial carcinoma following radical nephroureterectomy
講者: 陳怡璇 座長: 黃昭淵,
高建璋
14:00 ~ 14:10
PD09-6: Initial antibiotics choice may not be associated with the prognosis of fournier’s gangrene
講者: 張哲綱 座長: 黃昭淵,
高建璋